Sign in
Groups
Researchers
Results
ELENA
GALVE CALVO
Institute Catalá Oncología
Barcelona, España
You are in
Collaborations
Institute Catalá Oncología
Publications in collaboration with researchers from Institute Catalá Oncología (1)
2022
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
Breast, Vol. 66, pp. 77-84
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
eu
fr
de